Paloma Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-482
| Closed | -$63.6K | – | 1501 |
|
|
2024
Q1 | $63.6K | Sell |
482
-2,330
| -83% | -$291K | ﹤0.01% | 687 |
|
|
2023
Q4 | $342K | Buy |
2,812
+2,679
| +2,014% | +$299K | 0.01% | 574 |
|
|
2023
Q3 | $14.9K | Buy |
+133
| New | +$16.9K | ﹤0.01% | 651 |
|
|
2023
Q1 | – | Sell |
-3,109
| Closed | -$390K | – | 1016 |
|
|
2022
Q4 | $396K | Buy |
+3,109
| New | +$361K | 0.02% | 580 |
|
|
2022
Q1 | – | Sell |
-106,113
| Closed | -$13.1M | – | 2307 |
|
|
2021
Q4 | $13.1M | Buy |
106,113
+97,579
| +1,143% | +$12.8M | 0.19% | 64 |
|
|
2021
Q3 | $1.21M | Buy |
8,534
+3,280
| +62% | +$482K | 0.03% | 312 |
|
|
2021
Q2 | $820K | Sell |
5,254
-2,342
| -31% | -$379K | 0.01% | 741 |
|
|
2021
Q1 | $1.18M | Buy |
7,596
+2,710
| +55% | +$420K | 0.02% | 620 |
|
|
2020
Q4 | $731K | Buy |
4,886
+90
| +2% | +$12.7K | 0.02% | 711 |
|
|
2020
Q3 | $634K | Sell |
4,796
-81,970
| -94% | -$10.7M | 0.02% | 1006 |
|
|
2020
Q2 | $10.1M | Buy |
+86,766
| New | +$10M | 0.17% | 106 |
|
|
2019
Q4 | – | Sell |
-17,304
| Closed | -$2.31M | – | 2566 |
|
|
2019
Q3 | $2.31M | Sell |
17,304
-1,273
| -7% | -$164K | 0.05% | 366 |
|
|
2019
Q2 | $2.12M | Buy |
18,577
+9,101
| +96% | +$1.07M | 0.04% | 401 |
|
|
2019
Q1 | $1.18M | Buy |
9,476
+3,471
| +58% | +$394K | 0.03% | 654 |
|
|
2018
Q4 | $604K | Buy |
6,005
+4,254
| +243% | +$478K | 0.02% | 606 |
|
|
2018
Q3 | $223K | Sell |
1,751
-2,370
| -58% | -$282K | ﹤0.01% | 1350 |
|
|
2018
Q2 | $446K | Sell |
4,121
-10,630
| -72% | -$1.16M | 0.01% | 1087 |
|
|
2018
Q1 | $1.56M | Buy |
14,751
+11,459
| +348% | +$1.33M | 0.02% | 720 |
|
|
2017
Q4 | $385K | Buy |
+3,292
| New | +$372K | 0.01% | 1441 |
|
|
2017
Q2 | – | Sell |
-5,872
| Closed | -$696K | – | 2483 |
|
|
2017
Q1 | $696K | Buy |
+5,872
| New | +$666K | 0.01% | 1449 |
|
|
2016
Q4 | – | Sell |
-9,152
| Closed | -$1.16M | – | 2187 |
|
|
2016
Q3 | $1.16M | Buy |
9,152
+877
| +11% | +$108K | 0.01% | 905 |
|
|
2016
Q2 | $967K | Buy |
8,275
+6,296
| +318% | +$713K | 0.01% | 1175 |
|
|
2016
Q1 | $205K | Sell |
1,979
-11,478
| -85% | -$1.11M | ﹤0.01% | 1684 |
|
|
2015
Q4 | $1.34M | Buy |
13,457
+2,754
| +26% | +$269K | 0.04% | 531 |
|
|
2015
Q3 | $976K | Sell |
10,703
-38,270
| -78% | -$3.84M | 0.02% | 666 |
|
|
2015
Q2 | $5.19M | Buy |
48,973
+20,236
| +70% | +$2.24M | 0.1% | 193 |
|
|
2015
Q1 | $3.28M | Buy |
28,737
+23,072
| +407% | +$2.63M | 0.09% | 186 |
|
|
2014
Q4 | $624K | Sell |
5,665
-11,161
| -66% | -$1.18M | 0.03% | 589 |
|
|
2014
Q3 | $1.64M | Buy |
16,826
+554
| +3% | +$54.5K | 0.08% | 260 |
|
|
2014
Q2 | $1.64M | Buy |
+16,272
| New | +$1.59M | 0.07% | 263 |
|
Other funds holding ZBH
Paloma Partners's ZBH Position: Q2 2024 in Review
Paloma Partners sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 482 shares — an estimated $63.6K sold.
Paloma Partners first reported a position in ZBH in Q2 2014 and held it in 30 quarters. The position peaked at $13.1M in Q4 2021. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.
- Paloma Partners reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
- Paloma Partners sold 482 Zimmer Biomet shares in Q2 2024, an estimated $63.6K.
- Paloma Partners first reported a position in Zimmer Biomet in Q2 2014 and held it in 30 quarters.
- Paloma Partners's Zimmer Biomet position peaked at $13.1M in Q4 2021.
- 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.
Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.